Format

Send to

Choose Destination
Nat Med. 2019 Jun;25(6):879-882. doi: 10.1038/s41591-019-0482-7.

Combining checkpoint inhibition and targeted therapy in melanoma.

Author information

1
Department of Medical Oncology and Division of Molecular pathology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
2
Department of Medical Oncology and Division of Molecular pathology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands. c.blank@nki.nl.
PMID:
31171877
DOI:
10.1038/s41591-019-0482-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center